Drug Shortage Report for CELESTONE SOLUSPAN
| Report ID | 182292 |
| Drug Identification Number | 00028096 |
| Brand name | CELESTONE SOLUSPAN |
| Common or Proper name | BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAMETHASONE BETAMETHASONE ACETATE |
| Strength(s) | 3MG 3MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRAMUSCULAR INTRADERMAL INTRABURSAL INTRA-ARTICULAR |
| Packaging size | 5ML VIAL |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-04-21 |
| Actual start date | 2023-03-29 |
| Estimated end date | 2023-11-17 |
| Actual end date | 2023-11-15 |
| Shortage status | Resolved |
| Updated date | 2023-11-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-01-25 | English | Compare |
| v1 | 2023-01-25 | English | Compare |